✅ Final Thoughts Friday for 2025-10-10

October 10, 2025

💊 + 🤖 The story that caught my eye this week was life sciences companies placing ever bigger bets on our new AI overlords.

The big story this week was AstraZeneca’s $555M deal to develop new drugs which signals a strategic shift from the petri dish alone to the processing core contribution as a catalyst. This isn’t about saving pennies on lab coats; it’s about compressing the multi-billion dollar, decade-long R&D cycle timeline into a high-speed computational augmented sprint.

The race (metaphor or otherwise) is on to see if the cure for what ails you is found in a molecule or an algorithm.

Of course, this shift also means that the attention to so-called “open” life sciences movements is increasingly important as AI computation is rapidly democratized to more than the best funded and already established life sciences companies.

View this page on GitHub.